Holen Sie sich die Stockscreener-App
9.91
3.24%
-0.28
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$10.19
Offen:
$10.02
24-Stunden-Volumen:
1.09M
Relative Volume:
0.26
Marktkapitalisierung:
$1.64B
Einnahmen:
$596.34M
Nettoeinkommen (Verlust:
$-87.84M
KGV:
-16.59
EPS:
-0.5975
Netto-Cashflow:
$-97.62M
1W Leistung:
-4.46%
1M Leistung:
+24.02%
6M Leistung:
-6.54%
1J Leistung:
+23.87%
1-Tages-Spanne:
$9.825
$10.24
1-Wochen-Bereich:
$9.75
$10.75
52-Wochen-Spanne:
$6.20
$11.97
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
21 FIRSTFIELD RD, GAITHERSBURG, MD
Compare NVAX vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
9.925 | 1.68B | 596.34M | -87.84M | -97.62M | -0.5975 |
VRTX
Vertex Pharmaceuticals Inc
|
522.22 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
800.12 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
999.14 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
139.10 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.35 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-20 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Eingeleitet | Citigroup | Sell |
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
GOOGL Stock Price TodayAlphabet Inc Class A News, Charts, Retail Sentiment - Stocktwits
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - Stocktwits
NVAX Form 4 FilingsNovavax Inc SEC Form 4 - Stock Titan
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
Trading the Move, Not the Narrative: (NVAX) Edition - Stock Traders Daily
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - Stocktwits
Novavax Inc. stock underperforms Friday when compared to competitors - marketwatch.com
Novavax Inc (NVAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - tradingkey.com
Novavax to Participate in September Investor Conferences - morningstar.com
Novavax Inc. stock outperforms competitors on strong trading day - marketwatch.com
Novavax Stock Rises Despite No Confirmed News Behind the Matrix-M Rumor - Benzinga
Novavax Jumps 6% on Matrix-M Oncology Speculation: Is the Royalty Model the Real Story? - Yahoo Finance
What's Going On With Novavax Stock? - Benzinga
Novavax's Nuvaxovid Gets XFG-Variant Approval in US, EU, and Japan Ahead of 2026-2027 Season - BioPharm International
Novavax Stock Climbs Monday: What's Going On? - Benzinga
How Expanded Nuvaxovid Royalties and Partner-led Execution Could Shape Novavax’s (NVAX) Investment Narrative - Yahoo Finance
Has Novavax (NVAX) Fallen Far Enough To Look Cheap? - Yahoo Finance
NVAX Stock Climbs As Partnership Model Keeps COVID Vaccine Cash Flow Open - TradingView
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax -- Update - marketscreener.com
Gaithersburg's Novavax Sees Its Licensing Strategy Pay Off With XFG Vaccine Approvals Across Three Major Markets - biobuzz.io
Novavax partners receive approvals for updated COVID-19 vaccine By Investing.com - Investing.com Canada
Novavax's protein-based COVID vaccine gets approvals in the U.S., EU and Japan - Stock Titan
Novavax partners receive approvals for updated COVID-19 vaccine - Investing.com
QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax - Benzinga
Novavax Inc. stock underperforms Thursday when compared to competitors - marketwatch.com
Novavax Inc. stock underperforms Wednesday when compared to competitors - marketwatch.com
Novavax Stock Pulls Back After Milestone Vaccine Success - Yahoo Finance
Novavax Stock Rallies Tuesday: What's Happening? - TradingView
Stocks making big moves this week: Bally's, Adobe, Novavax, Semtech, and STAAR Surgical - Yahoo Finance
NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough - Barchart.com
Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why - Sahm
Novavax Inc. Stock Rallies 10.8%, Outperforms Peers - webull.com
Recursion, Novavax, Crispr Therapeutics Stocks Slip Premarket After Cancer Therapy RallyRecursion Phar - Benzinga
Novavax Inc. Stock Slips 4.2%, Underperforms Peers - webull.com
Novavax (NVAX) Is Up 10.4% After Steep Q2 Revenue Drop And Swing To Net Loss – Has The Bull Case Changed? - simplywall.st
Novavax (NVAX) Shares Skyrocket, What You Need To Know - Yahoo Finance
Novavax Stock Moves Higher Wednesday: What's Driving the Action? - TradingView
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):